Expandable Drug Delivery Device

Hartop February 11, 1

Patent Grant 3865108

U.S. patent number 3,865,108 [Application Number 05/377,350] was granted by the patent office on 1975-02-11 for expandable drug delivery device. This patent grant is currently assigned to Ortho Pharmaceutical Corporation. Invention is credited to William L. Hartop.


United States Patent 3,865,108
Hartop February 11, 1975

EXPANDABLE DRUG DELIVERY DEVICE

Abstract

A drug delivery device having a drug containing zone associated with and partially defined by a material which swells on contact with body fluids. When swelling occurs, the pressure on the drug containing zone expels the drug from the device.


Inventors: Hartop; William L. (Bernardsville, NJ)
Assignee: Ortho Pharmaceutical Corporation (Raritan, NJ)
Family ID: 26841747
Appl. No.: 05/377,350
Filed: July 9, 1973

Related U.S. Patent Documents

Application Number Filing Date Patent Number Issue Date
144174 May 17, 1971

Current U.S. Class: 424/430; 424/434; 222/95; 424/436
Current CPC Class: A61M 31/002 (20130101); A61K 9/0039 (20130101)
Current International Class: A61K 9/00 (20060101); A61M 31/00 (20060101); A61m 031/00 ()
Field of Search: ;128/260,127,130,268,215,216,253,213,2W,2R,1R,329,330,333,314,315,270,271,285 ;222/92,95,206,103,105

References Cited [Referenced By]

U.S. Patent Documents
706778 August 1902 Pond
2643027 June 1953 Fink
2687729 August 1965 Slavin
2959250 November 1960 Minera
3102540 September 1963 Bentov
3202324 August 1965 Honnet et al.
3490454 January 1970 Goldfarb et al.
3559646 February 1971 Mullan
3760805 September 1973 Higuchi
3760984 September 1973 Theeuwes
Primary Examiner: Gaudet; Richard A.
Assistant Examiner: McGowan; J. C.
Attorney, Agent or Firm: Lambert; Benjamin F.

Parent Case Text



This is a continuation-in-part of co-pending application Ser. No. 144,174 filed May 17, 1971, now abandoned.
Claims



What is claimed is:

1. A device for the delivery of a medicament to a body cavity comprising a base, said base at least partially defining a medicament containing zone of restricted dimensions, said base being expandable and incorporating a material which expands sufficiently upon contact with body fluids to expand said base, said material being selected from the group consisting of brown algae, polysaccharides derived from brown and red seaweeds, biosynthetic polysaccharides, natural gums, cellulose derivatives, synthetic resins derived from cellulose, polyacrylamide, polyvinylpyrrolidone, ethylene oxide polymers, and modified starches, and said medicament containing zone being disposed in pressure responsive relation to said expandable base such that upon insertion of the device into a body cavity pressure is exerted on the medicament containing zone as a result of resistance to expansion by the base within the body cavity which causes the base to compress the medicament containing zone resulting in the medicament contained therein being dispensed into the body cavity.

2. The device of claim 1 wherein said base is comprised of a polymeric material and defines a hollow core which constitutes said medicament containing zone.

3. The device of claim 1 wherein said expandable material is Laminaria.

4. The device of claim 2 wherein said core contains a collapsible capillary tube containing said medicament.

5. The device of claim 4 in which said capillary is of oval cross-section.

6. The device of claim 1 in which a collapsible capillary tube containing said medicament is disposed in fixed position adjacent the surface of said base and the peripheral surface of said tube defining an annular medicament containing zone.

7. The device of claim 4 in which said capillary contains an inner rib along substantially its entire length.

8. The device of claim 4 in which the capillary contains a plurality of inner ribs along substantially its entire length.

9. The device of claim 4 in which the capillary tube is of rectangular cross-section.

10. The device of claim 6 in which said capillary contains an inner rib along substantially its entire length.
Description



Current methods of introducing medicaments such as prostaglandins, for example, into the uterine cavity for the purpose of abortion and the like require the use of in-dwelling catheters and the continual attention of medical personnel to deliver the drug by use of a syringe or by hydrostatic pressure from an outside reservoir. The device of this invention obviates the need for an in-dwelling catheter and, more importantly, eliminates the need for an operator to monitor the administration of the drug.

The device of this invention comprises a generally cylindrical or prismatic base incorporating a substance which swells upon contact with natural body fluids. The base of the device either defines a hollow core containing a medicament or has disposed in a relatively restrained position around or adjacent its outer surface a medicament containing tube or sheath. In other words, the base at least partially defines a medicament containing zone of restricted dimensions. In either case, the medicament is dispensed into the body cavity due to the pressure generated on the medicament containing zone by virtue of the swelling of the base.

The invention may be better understood by reference to the attached drawings, wherein

FIG. 1 is a longitudinal cross-section of a device of this invention;

FIG. 2 is a vertical cross-section of the device of FIG. 1 taken along lines 2--2;

FIG. 3 is a longitudinal cross-section of the device of FIGS. 1 and 2 after use;

FIG. 4 is a vertical cross-section of the used device of FIG. 3 taken along lines 4--4;

FIG. 5 is a longitudinal cross-section of another device of this invention;

FIG. 6 is a vertical cross-section of the device of FIG. 5 taken along lines 6--6;

FIG. 7 is a vertical cross-section of still another device of this invention illustrating the same both before and after exposure;

FIG. 8 also is a vertical cross-section of another device of this invention illustrating the same both before and after exposure;

FIG. 9 is a vertical cross-section of yet another device of this invention illustrating the same both before and after exposure;

FIG. 10 is a view in perspective of still another device of this invention;

FIG. 11 is a cross-section of the device of FIG. 10 taken along lines 11--11;

FIG. 12 is a vertical cross-section of another device of this invention;

FIG. 13 is a top view of another device of this invention;

FIG. 14 is a top view of yet another device of this invention.

FIGS. 1 through 11 illustrate embodiments of the invention wherein the base of the device defines a hollow medicament filled core. The device of FIGS. 1 and 2 consists of a base, 1, formed of a material which will expand multi-directionally upon contact with body fluids, the base defining a hollow core, 2. The hollow core, 2, contains a medicament, 3, which is encased in a collapsible tube, 4, having a closed end, 5, projecting outward from the end, 6, of the base, 1.

When in use, the end of the collapsible tube is severed and the device inserted into a body cavity such as the cervix. The base, 1, will expand multi-directionally upon contact with body fluid and the resistance to expansion offered by the cervix causes the tube to collapse and the medicament to be dispensed into the body cavity. The cervical canal is gradually enlarged to accommodate the increased dimensions. Thus, when used to dispense a medicament for the termination of pregnancy, for example, the dilation of the cervix will facilitate the abortion.

FIGS. 3 and 4 illustrate the device of FIGS. 1 and 2 after use. In FIGS. 3 and 4, the capillary tube, 4, has been compressed and its contents have been expelled into the uterine cavity.

While the device may be of any shape, it is preferred that it be prismatic or cylindrical for enhancing comfort and facilitating insertion. The device also preferably has a tail, 7, to assist in its removal after use. It may also be advantageous to mold the base of the device with an enlarged end portion, 8, to prevent the device from accidentally being inserted completely into the uterus. It is not practical to give a particular dimension for the device since the size employed will depend upon whether the device is used in the nostrils, vagina, for treating rectal disorders, etc.

The base of the device is made either primarily of a material which will itself expand upon contact with body fluids, or is made of an expandable material having incorporated therein a substance which will expand upon contact with body fluids. By expandable material is meant a material which will swell or expand beyond its original or normal limits. Examples of such expandable materials include brown algae, in particular species of the genus Laminaria; polysaccharides derived from brown and red seaweeds, such as alkali metal and ammonium salts of alginic acids and carrageenan; biosynthetic polysaccharides such as xanthan gum; natural gums, such as guar gum, karaya, tragacanth, psyllium seed, and locust bean; cellulose derivatives such as microcrystallinecellulose; synthetic resins derived from cellulose, such as carboxymethylcellulose, and non-ionic cellulose gums such as methylcellulose and hydroxypropyl cellulose; synthetic water-absorbing polymers such as polyvinyl alcohol, polyacrylamide, polyvinylpyrrolidone, and ethylene oxide polymers; and modified starches such as pre-gelatinized corn starch. Preferred among the expandable materials are those derived from brown algae and in particular those derived from species of the genus Laminaria.

In practice, the capillary tube may be constructed of any thin, easily collapsible metal or plastic material such as aluminum or Teflon. The material must have sufficient strength to protect the medicament during storage prior to use, but at the time of use must be easily severable and collapsible. The collapsible tube, and the hollow core, preferably have an oval cross-section to facilitate collapse under pressure; however, any convenient shape may be utilized.

In some cases, it may be desirable to encase the base in an outer skin of highly flexible water-permeable material, 9a, such as is illustrated in FIGS. 5 and 6. Such a skin assures that the device will not break apart upon softening and swelling when in contact with body fluids. It may be advantageous to form such a skin of a material having a high modulus of elasticity so as to exert added pressure on the medicament containing zone as the base attempts to expand.

It is possible to further improve the operation of the device by modifying the collapsible tube to prevent entrapment of the drug due to irregular collapse of segments of the tube. Irregular collapse can be avoided by molding a longitudinal rib, 10b, inside the tube as shown in FIG. 7. Thus, the rib will allow passage of a medicament on either side of it after the tube has collapsed. This may also be accomplished by disposing ribs, 10c, at each side of the tube as shown in FIG. 8. Irregular collapse may also be overcome by providing a tube with a rectangular cross-section of appropriate stiffness so that the short side walls, 11d, tend to resist collapse and thus permit passage of the drug through the spaces adjacent them as illustrated in FIG. 9.

While it was indicated at the outset that the device is preferably cylindrical or prismatic, this does not mean that the base must be formed of only one such solid. As illustrated in FIG. 10, the base may be of any shape as long as it has smooth sides and corners, and defines a hollow core into which the medicament or a capillary containing the medicament may be inserted. The device of FIG. 10 consists of a series of four rods, 101, of a material which swells when in contact with body fluids, arranged in a bundle so as to leave an open core, 102, sufficient to hold a small capillary, 104, containing the active drug, 103. The rods may be kept in their illustrated configuration by an outer water-permeable covering, 109, such as the type previously described. The expansion of the rods will fill the void occupied by the capillary and thus extrude the contents into the body cavity.

A particularly adaptable substance for a device of this design is the stalk of the seaweed of the Laminaria family which, when dried, becomes rigid and bone-like. When exposed to water, the stalk will increase in diameter nearly three-fold and become soft and flexible.

As an example of the device illustrated in FIGS. 10 and 11, and the manner in which it functions, four rods of Laminaria, each about 21/2 inches long and about 1/8 of an inch in diameter are bound firmly together by means of fine copper wire. A catheter having an inside diameter of 0.025 inches and an outside diameter of 0.047 inches is inserted longitudinally through the space between the rods, is filled with a vegetable dye solution and one end is clamped off. When the device is immersed in water, within 12 minutes the dye solution can be observed issuing from the open end of the catheter. The dye continues to be expelled very slowly at what appears to be a uniform rate for a total of one hour and 20 minutes. Calculations indicate that the rate of expulsion of the dye cannot have exceeded 1 .times. 10.sup..sup.-3 ml. per minute. This rate conforms to the concept of the delivery of very small doses of highly active medicaments in a continuous fashion.

FIGS. 12 through 14 illustrate embodiments of the invention wherein the base of the device has a medicament containing tube or sheath disposed in a relatively restrained position around or adjacent its outer surface. Referring specifically to FIG. 12, the base, 201, of the device illustrated constitutes a solid core surrounded by medicament, 203, encased in a sheath, 209. The sheath is not permeable to fluids but the base absorbs body fluids through its ends thus causing the desired effect.

Referring to FIG. 13, the medicament containing tube, 304, of the device illustrated therein is helically wound around the base, 301, and anchored by passing it through the base at either end, 310. As the base expands, medicament is delivered through one of the ends, 310.

Finally, referring to FIG. 14, the medicament containing tube, 404, of the device illustrated therein is secured adjacent to the surface of the base, 401, by passing the same through the base at either end, 410. As the base expands, medicament is delivered through one of the ends, 410.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed